Microbiota derived d-malate inhibits skeletal muscle growth and angiogenesis during aging via acetylation of Cyclin A.

Metabolites derived from the intestinal microbiota play an important role in maintaining skeletal muscle growth, function, and metabolism. Here, we found that D-malate (DMA) is produced by mouse intestinal microorganisms and its levels increase during aging. Moreover, we observed that dietary supplementation of 2% DMA inhibits metabolism in mice, resulting in reduced muscle mass, strength, and the number of blood vessels, as well as the skeletal muscle fiber type I/IIb ratio. In vitro assays demonstrate that DMA decreases the proliferation of vascular endothelial cells and suppresses the formation of blood vessels. In vivo, we further demonstrated that boosting angiogenesis by muscular VEGFB injection rescues the inhibitory effects of d-malate on muscle mass and fiber area. By transcriptomics analysis, we identified that the mechanism underlying the effects of DMA depends on the elevated intracellular acetyl-CoA content and increased Cyclin A acetylation rather than redox balance. This study reveals a novel mechanism by which gut microbes impair muscle angiogenesis and may provide a therapeutic target for skeletal muscle dysfunction in cancer or aging. Synopsis: Microbiota derived d-malate, whose levels increase during aging, leads to inhibition of skeletal muscle growth by restraining angiogenesis. Intestinal microorganisms produce d-malate, which reduces skeletal muscle mass, strength, and fiber area. Suppressed angiogenesis is required for skeletal muscle mass loss induced by d-malate. An increase in cellular acetyl-CoA levels, global protein acetylation and Cyclin A2 play a key role in inhibition of angiogenesis in the muscle. Microbiota derived d-malate, whose levels increase during aging, leads to inhibition of skeletal muscle growth by restraining angiogenesis. [ABSTRACT FROM AUTHOR]